Macquarie Group Ltd. decreased its position in Mead Johnson Nutrition Co. (NYSE:MJN) by 83.9% during the second quarter, Holdings Channel reports. The firm owned 2,200 shares of the company’s stock after selling 11,450 shares during the period. Macquarie Group Ltd.’s holdings in Mead Johnson Nutrition were worth $200,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. increased its position in shares of Mead Johnson Nutrition by 11.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,287 shares of the company’s stock worth $118,000 after buying an additional 131 shares during the period. Pinkerton Retirement Specialists LLC bought a new position in shares of Mead Johnson Nutrition during the second quarter worth about $128,000. Checchi Capital Advisers LLC boosted its stake in Mead Johnson Nutrition by 2.5% in the second quarter. Checchi Capital Advisers LLC now owns 1,418 shares of the company’s stock valued at $129,000 after buying an additional 35 shares in the last quarter. Feltz Wealth PLAN Inc. acquired a new stake in Mead Johnson Nutrition during the second quarter valued at approximately $180,000. Finally, East Coast Asset Management LLC. acquired a new stake in Mead Johnson Nutrition during the first quarter valued at approximately $208,000. Institutional investors own 96.93% of the company’s stock.
Shares of Mead Johnson Nutrition Co. (NYSE:MJN) opened at 79.08 on Tuesday. Mead Johnson Nutrition Co. has a one year low of $65.53 and a one year high of $94.40. The company’s 50-day moving average price is $81.27 and its 200-day moving average price is $84.81. The company has a market capitalization of $14.60 billion, a price-to-earnings ratio of 29.75 and a beta of 1.26.
Mead Johnson Nutrition (NYSE:MJN) last posted its earnings results on Thursday, July 28th. The company reported $0.88 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.10. Mead Johnson Nutrition had a negative return on equity of 194.30% and a net margin of 13.28%. The firm had revenue of $941.50 million for the quarter, compared to the consensus estimate of $967.25 million. During the same quarter in the prior year, the business earned $0.76 EPS. The business’s revenue for the quarter was down 8.8% on a year-over-year basis. On average, equities research analysts predict that Mead Johnson Nutrition Co. will post $3.48 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Monday, October 3rd. Shareholders of record on Monday, September 19th were issued a dividend of $0.4125 per share. The ex-dividend date was Thursday, September 15th. This represents a $1.65 dividend on an annualized basis and a dividend yield of 2.09%. Mead Johnson Nutrition’s dividend payout ratio (DPR) is 62.03%.
Several research firms recently commented on MJN. Zacks Investment Research cut Mead Johnson Nutrition from a “hold” rating to a “sell” rating in a research note on Tuesday, July 26th. JPMorgan Chase & Co. raised Mead Johnson Nutrition from a “neutral” rating to an “overweight” rating and set a $105.00 target price for the company in a research note on Tuesday, July 26th. Citigroup Inc. raised their target price on Mead Johnson Nutrition from $100.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, July 25th. Deutsche Bank AG set a $88.00 target price on Mead Johnson Nutrition and gave the stock a “hold” rating in a research note on Sunday, July 24th. Finally, Goldman Sachs Group Inc. reaffirmed a “neutral” rating and set a $96.00 target price (up previously from $91.00) on shares of Mead Johnson Nutrition in a research note on Friday, July 15th. One analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $94.83.
In other Mead Johnson Nutrition news, Director Kimberly A. Casiano sold 710 shares of the company’s stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $89.75, for a total transaction of $63,722.50. Following the transaction, the director now owns 7,110 shares in the company, valued at approximately $638,122.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Graciela Monteagudo sold 45,873 shares of the company’s stock in a transaction that occurred on Friday, August 5th. The stock was sold at an average price of $87.64, for a total value of $4,020,309.72. Following the transaction, the senior vice president now owns 13,800 shares in the company, valued at approximately $1,209,432. The disclosure for this sale can be found here. Company insiders own 0.50% of the company’s stock.
About Mead Johnson Nutrition
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.
Want to see what other hedge funds are holding MJN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mead Johnson Nutrition Co. (NYSE:MJN).
Receive News & Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related companies with MarketBeat.com's FREE daily email newsletter.